doi.org/10.1016/s1556-0864(21)01941-9

99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation

,

,

..., P.A. Jänne

Journal of Thoracic Oncology20.80

Volume: 16, Issue: 4, Pages: S751 - S752

Published: Mar 27, 2021

Paper Fields

Paper Details

Title

99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation

DOI

doi.org/10.1016/s1556-0864(21)01941-9

Published Date

Mar 27, 2021

Journal

Journal of Thoracic Oncology

Volume

16

Issue

4

Pages

S751 - S752

Notes

History